tcp pharma limited
tcp pharma limited Company Information
Company Number
10921842
Next Accounts
38 days late
Shareholders
dalwinder chahal
navdeep chahal
Group Structure
View All
Industry
Dispensing chemist in specialised stores
Registered Address
office 1 21 hatherton street, walsall, WS4 2LA
Website
-tcp pharma limited Estimated Valuation
Pomanda estimates the enterprise value of TCP PHARMA LIMITED at £872.4k based on a Turnover of £2.5m and 0.34x industry multiple (adjusted for size and gross margin).
tcp pharma limited Estimated Valuation
Pomanda estimates the enterprise value of TCP PHARMA LIMITED at £6.3m based on an EBITDA of £1.6m and a 3.95x industry multiple (adjusted for size and gross margin).
tcp pharma limited Estimated Valuation
Pomanda estimates the enterprise value of TCP PHARMA LIMITED at £2.4m based on Net Assets of £1.2m and 2.09x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Tcp Pharma Limited Overview
Tcp Pharma Limited is a live company located in walsall, WS4 2LA with a Companies House number of 10921842. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in August 2017, it's largest shareholder is dalwinder chahal with a 50% stake. Tcp Pharma Limited is a young, small sized company, Pomanda has estimated its turnover at £2.5m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Tcp Pharma Limited Health Check
Pomanda's financial health check has awarded Tcp Pharma Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
4 Regular
5 Weak
Size
annual sales of £2.5m, make it smaller than the average company (£11.9m)
- Tcp Pharma Limited
£11.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 116%, show it is growing at a faster rate (5.8%)
- Tcp Pharma Limited
5.8% - Industry AVG
Production
with a gross margin of 32.7%, this company has a comparable cost of product (32.7%)
- Tcp Pharma Limited
32.7% - Industry AVG
Profitability
an operating margin of 45.5% make it more profitable than the average company (3.3%)
- Tcp Pharma Limited
3.3% - Industry AVG
Employees
with 16 employees, this is below the industry average (76)
16 - Tcp Pharma Limited
76 - Industry AVG
Pay Structure
on an average salary of £25.2k, the company has an equivalent pay structure (£25.2k)
- Tcp Pharma Limited
£25.2k - Industry AVG
Efficiency
resulting in sales per employee of £158.2k, this is equally as efficient (£142.6k)
- Tcp Pharma Limited
£142.6k - Industry AVG
Debtor Days
it gets paid by customers after 35 days, this is near the average (30 days)
- Tcp Pharma Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 147 days, this is slower than average (65 days)
- Tcp Pharma Limited
65 days - Industry AVG
Stock Days
it holds stock equivalent to 69 days, this is more than average (36 days)
- Tcp Pharma Limited
36 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (16 weeks)
1 weeks - Tcp Pharma Limited
16 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 77.3%, this is a higher level of debt than the average (56.6%)
77.3% - Tcp Pharma Limited
56.6% - Industry AVG
TCP PHARMA LIMITED financials
Tcp Pharma Limited's latest turnover from April 2023 is estimated at £2.5 million and the company has net assets of £1.2 million. According to their latest financial statements, Tcp Pharma Limited has 16 employees and maintains cash reserves of £66.6 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | ||||||
| Interest Payable | ||||||
| Interest Receivable | ||||||
| Pre-Tax Profit | ||||||
| Tax | ||||||
| Profit After Tax | ||||||
| Dividends Paid | ||||||
| Retained Profit | ||||||
| Employee Costs | ||||||
| Number Of Employees | 16 | 2 | 2 | 2 | 2 | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | |
|---|---|---|---|---|---|---|
| Tangible Assets | 202,643 | |||||
| Intangible Assets | ||||||
| Investments & Other | 3,517,719 | 2,204,570 | 2,204,570 | 2,204,570 | 2,204,570 | 2,204,570 |
| Debtors (Due After 1 year) | ||||||
| Total Fixed Assets | 3,720,362 | 2,204,570 | 2,204,570 | 2,204,570 | 2,204,570 | 2,204,570 |
| Stock & work in progress | 322,334 | |||||
| Trade Debtors | 246,793 | |||||
| Group Debtors | 45,246 | |||||
| Misc Debtors | 797,298 | 70,991 | 83,951 | 46,603 | ||
| Cash | 66,597 | 84 | 47 | 146 | 47 | 446 |
| misc current assets | ||||||
| total current assets | 1,433,022 | 71,075 | 83,998 | 46,749 | 45,293 | 446 |
| total assets | 5,153,384 | 2,275,645 | 2,288,568 | 2,251,319 | 2,249,863 | 2,205,016 |
| Bank overdraft | 132,725 | 130,925 | 118,048 | 120,089 | 120,267 | 119,390 |
| Bank loan | ||||||
| Trade Creditors | 685,825 | 57,904 | ||||
| Group/Directors Accounts | 214,196 | 299,446 | 376,166 | 892,818 | 676,983 | |
| other short term finances | ||||||
| hp & lease commitments | ||||||
| other current liabilities | 2,291,897 | 586,831 | 587,052 | 592,102 | 3,650 | 539,634 |
| total current liabilities | 3,110,447 | 931,952 | 1,004,546 | 1,088,357 | 1,016,735 | 1,393,911 |
| loans | 858,481 | 959,143 | 1,060,431 | 1,086,153 | 1,163,665 | 842,967 |
| hp & lease commitments | ||||||
| Accruals and Deferred Income | ||||||
| other liabilities | ||||||
| provisions | 15,931 | |||||
| total long term liabilities | 874,412 | 959,143 | 1,060,431 | 1,086,153 | 1,163,665 | 842,967 |
| total liabilities | 3,984,859 | 1,891,095 | 2,064,977 | 2,174,510 | 2,180,400 | 2,236,878 |
| net assets | 1,168,525 | 384,550 | 223,591 | 76,809 | 69,463 | -31,862 |
| total shareholders funds | 1,168,525 | 384,550 | 223,591 | 76,809 | 69,463 | -31,862 |
| Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | ||||||
| Depreciation | 207,829 | |||||
| Amortisation | 240,000 | |||||
| Tax | ||||||
| Stock | 322,334 | |||||
| Debtors | 973,100 | -12,960 | 37,348 | 1,357 | 45,246 | |
| Creditors | 685,825 | -57,904 | 57,904 | |||
| Accruals and Deferred Income | 1,705,066 | -221 | -5,050 | 588,452 | -535,984 | 539,634 |
| Deferred Taxes & Provisions | 15,931 | |||||
| Cash flow from operations | ||||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | 1,313,149 | 2,204,570 | ||||
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | ||||||
| Group/Directors Accounts | -214,196 | -85,250 | -76,720 | -516,652 | 215,835 | 676,983 |
| Other Short Term Loans | ||||||
| Long term loans | -100,662 | -101,288 | -25,722 | -77,512 | 320,698 | 842,967 |
| Hire Purchase and Lease Commitments | ||||||
| other long term liabilities | ||||||
| share issue | ||||||
| interest | ||||||
| cash flow from financing | ||||||
| cash and cash equivalents | ||||||
| cash | 66,513 | 37 | -99 | 99 | -399 | 446 |
| overdraft | 1,800 | 12,877 | -2,041 | -178 | 877 | 119,390 |
| change in cash | 64,713 | -12,840 | 1,942 | 277 | -1,276 | -118,944 |
tcp pharma limited Credit Report and Business Information
Tcp Pharma Limited Competitor Analysis
Perform a competitor analysis for tcp pharma limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in WS4 area or any other competitors across 12 key performance metrics.
tcp pharma limited Ownership
TCP PHARMA LIMITED group structure
Tcp Pharma Limited has 2 subsidiary companies.
Ultimate parent company
TCP PHARMA LIMITED
10921842
2 subsidiaries
tcp pharma limited directors
Tcp Pharma Limited currently has 2 directors. The longest serving directors include Mr Dalwinder Chahal (Aug 2017) and Mr Navdeep Chahal (Aug 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Dalwinder Chahal | England | 37 years | Aug 2017 | - | Director |
| Mr Navdeep Chahal | United Kingdom | 33 years | Aug 2017 | - | Director |
P&L
April 2023turnover
2.5m
+791%
operating profit
1.2m
0%
gross margin
32.8%
-2.18%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2023net assets
1.2m
+2.04%
total assets
5.2m
+1.26%
cash
66.6k
+791.82%
net assets
Total assets minus all liabilities
tcp pharma limited company details
company number
10921842
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
August 2017
age
8
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
April 2023
previous names
N/A
accountant
DHILLON ACCOUNTANTS LIMITED
auditor
-
address
office 1 21 hatherton street, walsall, WS4 2LA
Bank
-
Legal Advisor
-
tcp pharma limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to tcp pharma limited. Currently there are 4 open charges and 0 have been satisfied in the past.
tcp pharma limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for TCP PHARMA LIMITED. This can take several minutes, an email will notify you when this has completed.
tcp pharma limited Companies House Filings - See Documents
| date | description | view/download |
|---|
